molecular glues
Exclusive: Roivant-backed VantAI debuts AI model Neo-1, taking the big next step after AlphaFold 3
Neo-1, Study models, molecular glues
Biogen Expands Portfolio with Neomorph Molecular Glues Deal Worth Up to $1.45 Billion
Biogen, Neomorph, Molecular Glues, Biotech Deal, Pharmaceutical Acquisition
AstraZeneca Acquires Pinetree’s EGFR Degrader for $45 Million Upfront
AstraZeneca, Pinetree Therapeutics, EGFR degrader, protein degrader, oncology, licensing agreement, milestone payments, royalties, targeted protein degradation, molecular glues, cancer treatment